Skip to main content

Table 1 Demographics of patients and characteristics of bloodstream infection

From: Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection

Characteristic  
Male 52 (48%)
Median age, years 71 (IQR 57, 83)
Median days in hospital before bloodstream infection 0 (IQR 0, 1)
Median inpatient days after bloodstream infection 8 (IQR 5, 12)
Number admitted to OPAT 38 (35%)
Polymicrobial bloodstream infectiona 6 (6%)
Source of infection
 Complicated UTI 46 (43%)
 Uncomplicated UTI 35 (32%)
 Intra-abdominal other than biliary tract 11 (10%)
 Biliary tract 7 (6%)
 Febrile neutropenia 4 (4%)
 No focus 4 (4%)
 Native osteomyelitis 1 (1%)
Total duration of antimicrobial therapy, median, days 15 (IQR 12, 17)
Number treated with carbapenem 102 (94%)
Number de-escalated to oral therapyb 45 (42%)
 Median duration oral therapy, days 12 (IQR 6, 15)
30-day mortalityc 11/99 (11%)
  1. OPAT outpatient antimicrobial therapy, UTI urinary tract infection
  2. a 1 patient was bacteremic with both S. agalactiae and P. mirabilis, 2 patients had Staphylococcus aureus, 1 patient had Streptococcus anginosus group, 1 patient had Pseudomonas aeruginosa, 1 patient had Enterococcus raffinosus
  3. b 29 patients given ciprofloxacin, 10 trimethoprim-sulfamethoxazole, 3 trimethoprim, 2 oral fosfomycin, 1 nitrofurantoin,
  4. c 30-day follow-up not available for 9 patients